The venetoclax-based regimen was associated with an approximate $8000 decrease in costs compared with the continuous Bruton ...

Expert Rev Hematol. 2013;6(4):441-449. In conclusion, although age should generally determine the goal of treatment in CLL, the patient's functional status rather than chronological age can be ...

Stand Up To Cancer® (SU2C) today announced a collaboration with Johnson & Johnson aimed at supporting research testing a ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class ...

Allopurinol prophylaxis may be administered for the first few weeks of treatment for patients at high risk of TLS. At our institution, we administer allopurinol starting one or two days before ...

Eric Manes first appeared in the Discovery Channel (USA) docudrama Moonshiners, which premiered on December 6, 2011. Moonshine is alcohol distilled illegally in the United States.

BeiGene (BGNE) announced it will share new data across a range of B-cell malignancies and assets, including Bruton’s tyrosine kinase, or ...

SEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCLCoverage leverages new Medicare episode pricing ...

Emotional support from friends significantly enhances resilience during cancer treatment, providing comfort and ... As a ...

AZD5492 is currently being evaluated in Phase I clinical trials in R/R Non-Hodgkin lymphoma (NHL) and CLL. Voydeya (danicopan ... dose modification or treatment withdrawal. Separately, final long-term ...

Ascentage Pharma, a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies.